Poor prenatal detection rate of cardiac anomalies in Noonan syndrome

被引:25
作者
Menashe, M
Arbel, R
Raveh, D
Achiron, R
Yagel, S
机构
[1] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Ein Kerem, Israel
[3] Shaarei Tzedek Med Ctr, Dept Internal Med, Jerusalem, Israel
[4] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IL-52621 Tel Hashomer, Israel
关键词
congenital heart disease; Noonan syndrome; prenatal diagnosis;
D O I
10.1046/j.0960-7692.2001.00485.x
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Background The wide variation and nonspecific nature of many of the associated ultrasonographic findings complicate prenatal diagnosis of Noonan syndrome. The aim of the present study was to define the rate of prenatal diagnosis of heart malformations in cases diagnosed postnatally with Noonan syndrome. Methods English-language literature review of 29 cases of Noonan syndrome examined prenatally with confirmed postnatal diagnosis and four case reports from our center. Results Cases were evaluated for cervical spine pathologies, cardiac anomalies and other pathological findings, including hydrops fetalis and polyhydramnios. Cardiac anomalies were suspected in only nine of 33 cases, three of these were associated with cystic hygroma. Cardiac anomalies were eventually, diagnosed in 31133 cases postnatally. Polyhydramnios was diagnosed in 19133 cases in the third trimester, and hydrops fetalis was detected in eight of 33. Cystic hygroma was present in a total of nine cases at mid-trimester. Conclusions Noonan syndrome is characterized by late-onset and progressive pathologies, particularly the associated cardiac anomalies, which develop through the course of gestation and postnatal life. This complicates or precludes prenatal diagnosis at mid-trimester or at any time in the prenatal period, and partly explains the low rate of detection of fetal cardiac lesions in this syndrome.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 31 条
  • [1] Achiron R, 2000, AM J MED GENET, V92, P159, DOI 10.1002/(SICI)1096-8628(20000529)92:3<159::AID-AJMG1>3.0.CO
  • [2] 2-2
  • [3] NOONAN SYNDROME
    ALLANSON, JE
    [J]. JOURNAL OF MEDICAL GENETICS, 1987, 24 (01) : 9 - 13
  • [4] NONIMMUNE HYDROPS-FETALIS IN NOONANS SYNDROME
    BAWLE, EV
    BLACK, V
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1986, 140 (08): : 758 - 760
  • [5] BENACERRAF BR, 1989, J ULTRAS MED, V8, P59
  • [6] Further delineation of the critical region for Noonan syndrome on the long arm of chromosome 12
    Brady, AF
    Jamieson, CR
    vanderBurgt, I
    Crosby, A
    vanReen, M
    Kremer, H
    Mariman, E
    Patton, MA
    Jeffery, S
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1997, 5 (05) : 336 - 337
  • [7] BROWN BSJ, 1986, J CAN ASSOC RADIOL, V37, P164
  • [8] Brown DL, 1997, J ULTRAS MED, V16, P95
  • [9] CARDIOLOGIC ABNORMALITIES IN NOONAN SYNDROME - PHENOTYPIC DIAGNOSIS AND ECHOCARDIOGRAPHIC ASSESSMENT OF 118 PATIENTS
    BURCH, M
    SHARLAND, M
    SHINEBOURNE, E
    SMITH, G
    PATTON, M
    MCKENNA, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) : 1189 - 1192
  • [10] IN-UTERO PULMONARY-ARTERY AND AORTIC GROWTH AND POTENTIAL FOR PROGRESSION OF PULMONARY OUTFLOW TRACT OBSTRUCTION IN TETRALOGY OF FALLOT
    HORNBERGER, LK
    SANDERS, SP
    SAHN, DJ
    RICE, MJ
    SPEVAK, PJ
    BENACERRAF, BR
    MCDONALD, RW
    COLAN, SD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (03) : 739 - 745